Searching journal content for articles similar to McGuire et al. 24 (5): 719.

Displaying results 1-10 of 2949
For checked items
  1. .... 2022). The T2T-CHM13 has already seen use in the evaluation of novel tools (Formenti et al. 2022; Mc Cartney et al. 2022), characterization of SVs (Prodanov and Bansal 2022), and epigenetics (Gershman et al. 2022).During recent years, whole- sequencing (WGS) has been introduced as a clinical diagnostic...
  2. .... Corresponding authors: deepak.srivastava@gladstone.ucsf.edu, kpollard@gladstone.ucsf.eduAbstractExome sequencing of thousands of families has revealed many risk genes for congenital heart defects (CHDs), yet most cases cannot be explained by a single causal mutation. Even within the same family, individuals...
  3. ...Alekh Paranjapye1,2,4, Rili Ahmad1,2,4, Steven Su1, Abraham J. Waldman3, Jennifer E. Phillips-Cremins1,2,3, Shuo Zhang2 and Erica Korb1,2 1Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; 2Epigenetics Institute, Perelman School...
  4. ...nonlinearities while being simple and clinically plausible. Such a shape function is commonly used in risk prediction as it captures the scenario where contributions from single risk factors remain minimal until a critical threshold and then escalate (Wainberg et al. 2019; Liang et al. 2020; Zhao et al. 2023...
  5. ...expression of SLC14A, which rs9952980 is predicted to affect, by homozygous or heterozygous genotype.Clinically, carriers of the alternative allele (T) have less risk (beta: −0.0549) of developing breast cancer than do homozygous carriers of the reference allele (C). rs9952980 was previously predicted...
  6. ...-one-out design. We evaluated overall imputation accuracy from these different assays as well as overall power for GWAS from imputed data and computed polygenic risk scores for coronary artery disease and breast cancer using previously derived weights. We conclude that low-pass sequencing plus imputation...
  7. ...sclerosis, lupus, and other disorders. Previously, we showed that the EBV nuclear antigen 2 (EBNA2) transactivating protein occupies up to half of the risk loci for a set of seven autoimmune disorders. To further examine the mechanistic roles played by EBNA2 at these loci on a -wide scale, we globally...
  8. ...'s disease–associated risk loci and in the BCKDK Parkinson's disease–associated risk locus and assessed multiple aspects of their gene-regulatory influence in a human neuronal context. Together, this study reveals a novel layer of genetic variation in transposable elements that may contribute...
  9. ..., validation, and application populations are the same. The need for new methodology for prediction of genetic risk has been recognized ( Collins et al. 2003 ; Bell 2004 ; Khoury et al. 2006 ). Implementation of risk prediction in a clinical context has serious ethical and social implications ( Grosse...
  10. ...Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus Xiaoyang Zhang 1 , 4 , Richard Cowper-Sal·lari 1 , 2 , 4 , Swneke D. Bailey 3 , Jason H. Moore 1 , 2...
For checked items

Preprint Server